JP-2022516012-A5 -
JP2022516012A5JP 2022516012 A5JP2022516012 A5JP 2022516012A5JP-2022516012-A5
Dates
- Publication Date
- 20221228
- Application Date
- 20191220
Description
(Example 2) ADPIF/PATAS peptides are more effective at preventing hyperglycemia than PATAD peptides. Mice were injected with either scrambled peptide, PATAD, or ADPIF/PATAS as a single dose (25 micrograms per mouse). The results are from a series of glucose tolerance tests (ipGTT) in male DIO-intolerant mice (Figures 5A and 5B ).